TICKERNOMICS Sign up
Last Update: 2024-03-28 02:10:36
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) https://www.integralife.com
33.75USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-39.17%
IART
SPY
32.74%
-50.97%
IART
SPY
92.93%
-39.43%
IART
SPY
224.41%
IART
149.81%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2802.73
2708.46
0.77
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
27.79
1.82
1.77
1.91
0.00
22.55
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
6.95
57.10
7.87
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.8508
3.00
3.02
0.96
Other Earnings and Cash Flow Stats:
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Net Income TTM ($MM) is 146.58
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Operating Income TTM ($MM) is 195.86
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Owners' Earnings Annual ($MM) is 212.66
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Current Price to Owners' Earnings ratio is 16.82
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) EBITDA TTM ($MM) is 255.86
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) EBITDA Margin is 7.87%
Capital Allocation:
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) has paid 0.00 dividends per share and bought back 2.112169 million shares in the past 12 months
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) has reduced its debt by 1381.275 million USD in the last 12 months
Capital Structure:
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Interest-bearing Debt ($MM) as of last quarter is 182
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Annual Working Capital Investments ($MM) are 6
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Book Value ($MM) as of last quarter is 1587
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Debt/Capital as of last quarter is 11%
Other Balance Sheet Stats:
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) has 276 million in cash on hand as of last quarter
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) has 306 million of liabilities due within 12 months, and long term debt 1505 as of last quarter
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) has 81 common shares outstanding as of last quarter
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) has 0 million USD of preferred stock value
Academic Scores:
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Altman Z-Score is 1.85 as of last quarter
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) largest shareholder is AQR Capital Management LLC owning 764178 shares at 25.79 ($MM) value
Josh Gottheimer(an insider) Bought 0 shares of INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) for the amount of $0.00 on 2023-10-16
13.15% of INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) is held by insiders, and 92.34% is held by institutions
INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) went public on 1995-08-16
Other INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) financial metrics:
FCF:156.18
Unlevered Free Cash Flow:74.60
EPS:0.96
Operating Margin:6.95
Gross Profit Margin:57.10
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:4.91
Beta:0.96
Buffet's Owners Earnings:212.66
Price to Owner's Earnings:16.82
About INTEGRA LIFESCIENCES HOLDINGS CORP ( IART ) :
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.